Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial Reply

被引：0
|
作者：
Beaulieu, Wesley T.
Bressler, Neil M.
Gross, Jeffrey G.
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 177卷
关键词：
D O I：
10.1016/j.ajo.2017.02.010
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy Reply
    Luttrull, J. K.
    Musch, D.
    Spink, C.
    EYE, 2009, 23 (11) : 2123 - 2123
  • [22] Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study
    Lang, Gabriele E.
    Stahl, Andreas
    Voegeler, Jessica
    Quiering, Claudia
    Lorenz, Katrin
    Spital, Georg
    Liakopoulos, Sandra
    ACTA OPHTHALMOLOGICA, 2020, 98 (05) : E530 - E539
  • [23] Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
    Bressler, Susan B.
    Beaulieu, Wesley T.
    Glassman, Adam R.
    Gross, Jeffrey G.
    Jampol, Lee M.
    Melia, Michele
    Peters, Mark A.
    Rauser, Michael E.
    OPHTHALMOLOGY, 2017, 124 (04) : 431 - 439
  • [24] Writing Committee for the Diabetic Retinopathy Clinical Research Network. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial (vol 314, pg 2137, 2015)
    Gross, J. G.
    Glassman, A. R.
    Jampol, L. M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (09): : 944 - 944
  • [25] Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy
    Filho, Jose A. R.
    Messias, Andre
    Almeida, Felipe P. P.
    Ribeiro, Jefferson A. S.
    Costa, Rogerio A.
    Scott, Ingrid U.
    Jorge, Rodrigo
    ACTA OPHTHALMOLOGICA, 2011, 89 (07) : E567 - E572
  • [26] One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy
    Kaiser, RS
    Maguire, MG
    Grunwald, JE
    Lieb, D
    Jani, B
    Brucker, AJ
    Maguire, AM
    Ho, AC
    Fine, SL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (02) : 178 - 185
  • [27] Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy
    Ai-Yi Zhou
    Chen-Jing Zhou
    Jing Yao
    Yan-Long Quan
    Bai-Chao Ren
    Jian-Ming Wang
    International Journal of Ophthalmology, 2016, (12) : 1772 - 1778
  • [28] CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB
    Roohipoor, Ramak
    Sharifian, Elaheh
    Ghassemi, Fariba
    Riazi-Esfahani, Mohammad
    Karkhaneh, Reza
    Fard, Masoud Aghsaei
    Zarei, Mohammad
    Modjtahedi, Bobeck S.
    Moghimi, Sasan
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (10): : 1997 - 2005
  • [29] Efficacy and side effects of individualized versus standard panretinal photocoagulation for treatment-naive proliferative diabetic retinopathy: results from a randomized clinical trial
    Vergmann, Anna Stage
    Thao Thi Nguyen
    Torp, Thomas Lee
    Kawasaki, Ryo
    Tien Yin Wong
    Peto, Tunde
    Grauslund, Jakob
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [30] Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy
    Zhou, Ai-Yi
    Zhou, Chen-Jing
    Yao, Jing
    Quan, Yan-Long
    Ren, Bai-Chao
    Wang, Jian-Ming
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (12) : 1772 - 1778
12345